Summary. The aim of this study was to investigate the importance of inhibin in the delay in return to oestrus in heifers induced by steroid-stripped bovine follicular fluid (bFF). Oestrous We conclude that the suppression of follicular development and the subsequent delay in return to oestrus associated with bFF treatment of cattle is not due to inhibin.
Introduction
The administration of steroid-free bovine follicular fluid (bFF) to cattle or sheep at about the time of progesterone withdrawal results in a marked increase in the length of time to the return of oestrus owing to a suppression of follicular development (Miller et al, 1979 (Miller et al, , 1982 McNeilly, 1984 McNeilly, , 1985 Johnson & Smith, 1985 ; Wallace & McNeilly, 1985 Henderson et al, 1986; Quirk & Fortune, 1986) . In sheep, this follicular suppression is associated with, and has been attributed to, a decrease in peripheral concentrations of follicle-stimulating hormone (FSH) (Miller et al, 1982; McNeilly, 1984; Henderson et al, 1986 ; Hunter et al, 1988) . As the majority of the FSH-suppressing activity in steroid-stripped bFF is due to its inhibin content (Muttukrishna & Knight, 1990) , this delay in return to oestrus has been assumed to be due to the indirect action of inhibin on follicular growth. However, in intact cattle, Johnson & Smith (1985) could not demonstrate a suppression of FSH, in spite of a distinct delay in oestrus. Using smaller groups of animals, Quirk & Fortune (1986) suggested that reduced FSH was the reason for the delay in return to oestrus, but the changes in FSH seen during treatment were the same in both control and bFF-treated animals. Price & Webb (1988) have also demonstrated that steroids alone are the major components involved in the negative feedback regulation of FSH and luteinizing hormone (LH) secretion in heifers, whereas in sheep a protein component of follicular fluid (pre¬ sumably inhibin) is required for the full regulation of FSH concentrations (Martin et al, 1986 (Martin et al, , 1988 . This questions whether an inhibin-induced FSH-mediated action of bFF is operative in intact heifers.
In addition, several studies using hypophysectomized ewes treated with pregnant mares' serum gonadotrophin (PMSG) have suggested that follicular fluid proteins may act at the level of the ovary to suppress follicular growth directly (Cahill, 1984; Cahill et al, 1985; Larson et al, 1987) . In the light of these observations, we have investigated the importance of inhibin in the bFF-induced delay in return to oestrus after prostaglandin treatment in heifers. A preliminary report of these data has been presented elsewhere (Law et al, 1990 ).
Materials and Methods

Protocol
The animals used in the experiments were 2-year-old Hereford Friesian heifers. All were housed indoors at the Large Animal Unit of the Institute of Animal Physiology and Genetics Research, Roslin and were kept together throughout the experiment. They were maintained on a diet of hay and concentrates and fresh water was available ad libitum. Oestrous activity was synchronized in all animals with two i.m. injections containing 500 pg of a potent prostaglandin F2a analogue, cloprostenol (Estrumate: ICI pic, Macclesfield, Cheshire) given 12 days apart. At the time of the second PG injection (day 0), the animals were assigned at random to the experimental groups for treatment.
In a dose-response experiment (Expt 1), 24 animals were assigned to one of four experimental groups and each received i.v. injections of either 10 ml saline (control group, = 6) or 2-5 ml (n = 6), 5 ml (n = 6) or 10 ml (n = 6) steroid-free bFF every 8 h for 2 days, commencing at the time of the second prostaglandin injection.
In Expt 2, 18 animals were assigned to one of three experimental groups and each received i.v. injections of saline (control group, = 6), whole bFF (FF group, « = 6) or bFF, the inhibin content of which had been greatly reduced (-INH group, « = 6). As the material had been diluted during elution from the affinity column, each follicular fluid injection contained the protein equivalent of 20 ml untreated follicular fluid, twice the dose found in Expt 1 to delay oestrus consistently, diluted to 40 ml with saline. Control injections consisted of 40 Hormone assays FSH was determined using the homologous double antibody radioimmunoassay system described by Bolt & Rollins (1983) . All samples were measured in a single assay. The sensitivity of the assay, taken to be the dose of hormone required to suppress the binding of labelled hormone significantly below that observed in zero standards was 0-75 ng per tube (3-OOngml·1) and the within assay coefficient of variation calculated over the whole assay was 16-2%.
LH was similarly determined using a conventional double antibody radioimmunoassay routinely used in this laboratory (Price & Webb, 1988) . All samples were measured in a single assay with a mean intra-assay coefficient of variation calculated over the whole assay of 111%.
Progesterone was assayed directly in a single assay, using a modification of the radioimmunoassay routinely used in this laboratory (Price & Webb, 1988) . Steroids were dissociated from plasma binding proteins by the inclusion of 100 ng 8-anilino-l-naphthalenesulfonic acid per assay tube. The crossreactivities of various steroids were as pre¬ viously reported (Corrie et al., 1981) and progesterone added to plasma samples was recovered with a mean efficiency of 102% (±1-38 sem). The sensitivity of the assay was 7-8 pg per tube (0-16 ng ml· ') and the within assay coefficient of variation was 13-2%.
Oestradiol was assayed in pooled daily samples using the affinity extraction procedure described by Webb et al. (1985) . All samples were assayed in a single assay with a mean extraction efficiency of 5805 ± 001%. The sensitivity of the assay was 1-2 pg per tube and the within assay coefficient of variation was 13-9%.
Inhibin bioactivity was estimated by the ability of a sample to suppress basal FSH release from dispersed ovine pituitary cells in culture using the procedure of Tsonis et a!. (1986) , but with the addition of 10 ng RU486 ml·1 plus a highly specific oestradiol antisera (Land et al., 1982) at a dilution of 1:50 000 to prevent any possible steroid inter¬ ference. All media used in the cell culture procedure were obtained from Northumbria Biologicals Ltd. The lamb serum and donor bovine serum were obtained from Flow Laboratories, Rickmansworth, Hertfordshire. All samples, including the reference preparation, were stripped of steroids by incubation with 1 mg charcoal ml·1 plus 01 mg dextran ml·' overnight at 4°C and centrifugation for 1 h at 2000#, a process that removes approximately 99% of steroids (Wallace & McNeilly, 1985 Characterization offollicularfluidpools. Electrophoretic analysis of the fraction of bFF retained on the anti-inhibin column revealed the presence of multiple bands of staining differing in molecu¬ lar mass (see Fig. 1 ). Western blots of the bFF fraction retained on the column (see Fig. 2 ), using a specific antibody raised against a portion of the inhibin subunit (McNeilly et al, 1989) confirmed that the major band was inhibin of 32 kDa. Other bands corresponded to the multiple molecular mass species of inhibin initially described by Miyamoto et al (1986) , as well as to the 'free' monomeric subunits known to be present in bFF (Knight et al, 1989; Robertson et al, 1989; Sugino et al, 1989) . Adsorption of the first inhibin antibody with inhibin (porcine l-26a) prevented binding, thus confirming the specificity. The inhibin bioassay demonstrated that the inhibin-free follicular fluid fraction, with a bioactivity of 560 iu ml ' ( ± 75 iu ml~' ), contained less than 3% of the activity of a control follicular fluid pool (22 200 Follicle size. The mean diameter of the largest follicle on a pair of ovaries after one day of treatment was not significantly different (P > 005) between the two follicular fluid treatment groups (7-5 ± 0-4 mm versus 8-5 ± 0-9 mm; -INH versus FF groups), but the mean diameter of the largest follicle in the saline-treated control group of animals was significantly greater (P < 001) than that seen in the combined treatment groups (11 ± 0-9 mm versus 8-1 ± 0-5 mm; controls versus all treated animals).
Progesterone concentrations. Progesterone concentrations fell rapidly to below minimum detectable values in all animals after the second PG injection (Fig. 3a) . A steady and sustained increase was observed in control animals, commencing on day 6 and continuing to the end of the sampling period. Progesterone remained below minimum detectable concentrations in all animals in both treatment groups. Samples taken from treated animals on day 16 revealed that pro¬ gesterone concentrations had risen significantly above minimum detectable values by this time (data not shown).
Oestradiol concentrations. After PG injection at time 0, oestradiol concentrations rose rapidly in control animals, reaching a peak at about the time of onset of oestrus in these animals (Fig. 3b) . After oestrus, oestradiol fell rapidly to basal values and then subsequently rose to reach a second, smaller peak concentration at about day 8-9. In treated animals, oestradiol concentrations were initially suppressed below those seen in controls, but rose to a peak at about day 8-9, again coinci¬ dent with the onset of oestrus in these animals. The amplitude of the pre-ovulatory peak of oestra¬ diol in treated animals did not differ between treatments, but was significantly (P < 001) smaller than that seen in saline-treated controls. LH concentrations. Mean LH concentrations were initially high in all groups, but fell in control animals to values significantly lower (P < 0-01) than either treatment group by day 6, remaining so for the remainder of the sampling period (Fig. 4) .
FSH concentrations. FSH concentrations fell throughout the experimental period in all groups, including the controls (Fig. 5) (Johnson & Smith, 1985; Quirk & Fortune, 1986) , and confirmed by the ultrasound data. A similar ultrasound-monitored suppression of follicular development by bFF at various times throughout the oestrous cycle has also been reported (Kasteite et al, 1990 ). It has been suggested that, in sheep, the bFF-induced suppression of follicular development is due to an inhibin-mediated suppression of FSH secretion (Miller et al, 1982; McNeilly, 1984; Wallace & McNeilly, 1985 Henderson et al., 1986; Hunter et al, 1988) . However, in the present study in intact cattle, no such suppression of FSH secretion was observed. In addition, there was no difference in response to treatment with either intact, or 'inhibin-free' follicular fluid.
To our knowledge there is only one previous publication, using a smaller number of animals, reporting FSH concentrations following bFF treatment of intact adult cows at a similar stage of the oestrous cycle (Quirk & Fortune, 1986) . These authors claimed that the delay in oestrus was due to a reduction in FSH. However, FSH concentrations in treated animals were lower than those in controls before treatment started. Also in animals treated with 20 ml bFF for 24 h at 6 h intervals, a rebound of FSH appeared to have started before the last injection and without any preceding decrease in FSH. This apparent lack of effect of bFF treatment on circulating FSH concentrations is also supported by the finding that FSH can be maintained in the normal range in ovariectomized heifers with oestradiol and progesterone alone (Price & Webb, 1988) , unlike the case in sheep (Martin et al, 1988) . Furthermore, it has been demonstrated that there is an inverse relationship between the amount of oestradiol and intact inhibin, as measured by a highly specific two-site immunoradiometric assay for dimeric inhibin, in follicular fluid (Beard et al, 1991) . As most of the oestradiol emanates from the dominant follicle (Staigmiller et al, 1982) , this questions further the role of inhibin in the control of FSH in intact adult females.
Follicular fluid contains at least one other protein with FSH-suppressing activity, namely follistatin (Robertson et al, 1987; Ueno et al, 1987) . However, its potency is considerably less than that of inhibin (Robertson et al, 1990) , and co-incubation with specific anti-inhibin antisera com¬ pletely abolishes the FSH-suppressive action of bFF in ovine pituitary cell cultures (Muttukrishna & Knight, 1990) . Removal of the majority of the inhibin from follicular fluid would therefore be expected to remove the major part of any FSH-suppressing activity. The ability of the inhibin-free bFF to delay oestrus in this experiment would therefore suggest that the action of bFF in delaying oestrus is not related to its inhibin content. A recent report has also demonstrated that removal of 92% of the inhibin activity from bFF does not reduce its ability to suppress follicular development and delay oestrus in sheep (Campbell et al, 1991) . Immunoaffinity extraction of the bFF removed more than 95% of the inhibin in this study; the remaining activity was therefore equivalent to less than 1 ml whole bFF inhibin per injection. Since 2-5 ml of bFF in Expt 1 did not consistently delay oestrus, it is highly unlikely that the residual inhibin had any effect. In addition, Quirk & Fortune (1986) have previously failed to delay oestrus in half their animals using a dose of 10 ml bFF twice a day. Furthermore, bovine pituitary cells have been shown to be unresponsive to inhibin-containing preparations in vitro (Knight, 1991; A. S. Law & R. Webb, unpublished observations). The weight of evidence therefore suggests that the principal action of bFF in delaying oestrus in cattle is not mediated either by inhibin or through a reduced pituitary secretion of FSH.
One possible alternative mechanism by which bFF treatment may inhibit follicular develop¬ ment is through a reduction in LH concentrations. The repeated injection of LH alone into anoestrous sheep is clearly sufficient to overcome the hormonal inadequacies in this experimental model (McNeilly et al, 1982) , at least in breeds that have a shallow anoestrus, confirming that a reduced LH secretion can influence follicular development. However, mean daily LH concen¬ trations were unaffected by follicular fluid treatment in either this or other experiments (Miller et al, 1982; Johnson & Smith, 1985; Quirk & Fortune, 1986 ). In addition, Picton et al (1990) have demonstrated that basal LH is sufficient to support multiple follicular development in sheep. Furthermore, although pulsatile LH secretion was not measured in this study, other work has shown that LH pulse amplitude is actually increased by follicular fluid treatment Law, 1991) . A mode of action involving a suppression of LH release therefore seems unlikely. However, Picton et al (1990) have reported that increased LH pulse amplitude is detrimental to follicular development; this observation warrants further investigation.
Given that treatment failed to alter the mean concentration of either gonadotrophin, it is worthy of note that oestradiol secretion was significantly suppressed in treated animals. This observation suggests that the principal effect of follicular fluid treatment, rather than being mediated via a reduction in gonadotrophin concentrations per se, may involve a reduction in follicular responsive¬ ness to gonadotrophins. Indeed, evidence to support a direct ovarian action of bFF has already been documented in sheep; several groups using hypophysectomized ewes have demonstrated that bFF will suppress follicular development in the face of controlled PMSG treatment (Cahill, 1984; Cahill et al, 1985; Larson et al, 1987) . Furthermore, Fry et al. (1987) , using a similar model, have suggested that changes in gonadotrophin concentrations are not involved in the phenomenon of compensatory ovarian hypertrophy after unilateral ovariectomy. It would therefore appear that ovarian follicular proteins can act to suppress the development of other follicles in some manner independent of gonadotrophin concentrations.
The nature of the protein responsible for this action is uncertain. There are many proteins in follicular fluid, several of which have been characterized as having effects on the development and function of ovarian cells both in vivo and in vitro. The presence in bovine and porcine follicular fluid of a protein factor that was produced by the granulosa cells, and which prevented compen¬ satory ovarian hypertrophy in mice has been described (Sato & Ishibashi, 1977 . Similarly the ovary containing the preovulatory follicle secretes a protein, follicle-regulatory protein (FRP; diZerega et al, 1982) , which is produced by the granulosa cells (diZerega et al, 1983a; Tonetta et al, 1988) and which reduces the responsiveness of other follicles to gonado¬ trophins (diZerega et al, 1982 (diZerega et al, , 1983b . Injection of porcine FRP suppressed follicular development in cyclic monkeys (diZerega & Wilks, 1984) and guinea-pigs (Fujimori et al, 1987) . Other authors have also reported that porcine and bovine follicular fluid contain several factors that inhibit the binding of FSH to its receptor (Sluss et al, 1983 (Sluss et al, , 1987 (Sluss et al, , 1989 Sluss & Reichert, 1984a) , although this activity may be the result of bacterial action (Sluss & Reichert, 1984b) . Of particular note is the observation that the precursors of the a-inhibin molecule influence FSH binding and activity in vitro (Schneyer et al, 1991) , given that the inhibin-free bFF in this study was shown to contain some residual free a-inhibin subunit immunoactivity. Any one or more of these follicular fluid components may be responsible for the observed effects of bFF treatment. The exact nature of the active principle awaits further research.
Of additional interest is the observation of a 'rebound' increase in the secretion of FSH despite the absence of any prior suppression, in agreement with the findings of Johnson & Smith (1985) . The similarity of the rebound between intact and inhibin-stripped bFF-treated groups suggests that the rebound is not due to an action of inhibin. Campbell et al (1991) have also confirmed that this rebound of FSH is not mediated by inhibin in sheep. The timing of the FSH rebound in relation to the cessation of treatment suggests that another bFF protein, rather than inhibin, is involved in the negative feedback regulation of FSH. The maintenance of FSH concentrations in the face of reduced ovarian oestradiol production during the treatment period would further suggest that the action of the putative bFF factor is to increase the sensitivity of the pituitary gland to steroid negative feedback. These observations also warrant further investigation.
Waves of follicles develop regularly throughout the oestrous cycle (Sirois & Fortune, 1988; Savio et al, 1988 Savio et al, , 1990 ), but only the dominant follicle of the final wave ovulâtes. The process of ovulation presumably removes the factors responsible for the dominance of the ovulatory follicle and allows the initiation of the first non-ovulatory wave. The cessation of bFF treatment in this study was approximately coincident with the timing of oestrus and ovulation in the saline-treated control animals. The coincidental rise in oestradiol secretion in all groups from days 5 to 6 may therefore reflect a similar withdrawal of follicular suppression in all groups, suggesting that the factor(s) responsible for bFF-induced suppression of follicular development and follicular dominance are the same.
Interestingly, the size of the preovulatory peak of oestradiol was lower in both bFF-treated groups than in saline-treated controls. However, it was clearly sufficient to elicit oestrous behaviour and trigger the endocrine events leading to luteinization. The reasons for this reduced oestradiol secretion are not immediately apparent. Possibly the prolonged 'follicular phase' caused by the bFF treatment following the fall in progesterone at luteolysis resulted in an increase in the sensi¬ tivity of the hypothalamus/pituitary gland to oestradiol, and hence a premature initiation of the gonadotrophin surge, thus preventing the normal rise in oestradiol concentrations. Progesterone treatment has previously been demonstrated to delay the onset of the preovulatory gonadotrophin surge in GnRH-treated anoestrous ewes (McLeod et al, 1982) . Alternatively, the reduced oestra¬ diol secretion may be due to a direct action of the prior bFF treatment on the developing follicle. The dominant follicle of the primate ovarian cycle exerts effects on non-dominant follicles that remain even after ablation of the dominant follicle (diZerega & Hodgen, 1980) . Possibly such effects remained following bFF treatment in this study.
In conclusion, 
